Woman with Dexcom G7 sensor on right arm and wearing a tandem t:slim X2 pump smiling and holding surfboard

The most accurate CGM1,2 is now connected to the Tandem t:slim X2 pump!

  • Get started

More than 10 years as trusted partners in diabetes management

Dexcom G7 sensor spinning GIF

Dexcom G7

No fingersticks*
The only CGM that offers no fingersticks* from day 1
The fastest and most accurate1,2 CGM available
Only 30 minutes to warmup
Urgent Low Soon alert
Powering AID systems with a predictive Urgent Low Soon alert, notifying you of a serious low up to 20 minutes before it happens
Share and follow capabilities
Dexcom powers the only AID systems that enables you to share your numbers with up to 10 people§
*Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.
Tandem t:slim rotating GIF

Tandem t:slim X2™ pump

Increased time in range
Dexcom patients experience over 2.6 hours more time in range per day3,4
Automatic correction bolus
Offers up to 1 automatic correction bolus per hour
Customizable settings
Users can create up to 6 Personal Profiles based on insulin needs
Mobile bolus
With the t:connect mobile app, you can bolus from your smartphone,II giving you the freedom to wear your pump in more places

Getting started is easy.

Where do you get your Dexcom supplies from?

Durable Medical Equipment (DME) Distributor

Reach out to your DME distributor and mention you are on a Tandem automated insulin delivery system and would like to upgrade to Dexcom G7.

Pharmacy

Reach out to your healthcare provider for a Dexcom G7 prescription.

New to Dexcom?

Start on Dexcom G7 today and create your own connected story.

  • Get started

Our experts are here to help.

†Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer. ‡Audible and visual notification of predictive alert at 55mg/dl within 20 minutes.
§Separate Follow app and internet connection required. IIFor a list of compatible devices, visit dexcom.com/compatibility.
1 U.S. Food and Drug Administration, 510(k) Substantial Equivalence Determination Decision Summary, K213919. Published December 7, 2022. https://www.accessdata.fda.gov/cdrh_docs/reviews/K213919.pdf. 2 U.S. Food and Drug Administration, 510(k) Substantial Equivalence Determination Decision Summary, K222447. Published March 3, 2023. https://www.accessdata.fda.gov/cdrh_docs/reviews/K222447.pdf. 3 Brown SA, et al. N Engl J Med. 2019;381(18):1707-1717. 4 Breton MD, et al. N Engl J Med. 2020;383(9):836-845.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency. 
RX ONLY. The t:slim X2 insulin pump with Control-IQ technology is indicated for patients with type 1 diabetes, 6 years and older. BOXED WARNING: Control-IQ technology should not be used by people under age 6, or who use less than 10 units of insulin/day, or who weigh less than 55 lbs. For full safety information, visit tandemdiabetes.com/safetyinfo.
Tandem Diabetes Care, the Tandem logo, Control-IQ, and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.
Privacy PolicyTerms of Use

LBL-1001419 Rev008

MAT-0339

© Dexcom, Inc. All rights reserved.

US flag

US